News & Analysis on Clinical Trial Services & Contract Research And Development
Contract biopharmaceutical manufacturer SynCo Bio Partners has started construction of two new manufacturing suites at its facility in Amsterdam, the Netherlands, in a move that builds on the firm's ability to make microbial vaccines.
Animal activists' latest target in its campaign of terrorism has centred on a chain of children's nurseries that has links with the chemicals testing company, Huntingdon Life Sciences (HLS).
S R Pharma have released its interim results for the first half of 2005, which show the continued consolidation of Research and Development costs as resources were diverted to acquire contract development services provider, Atugen.
According to a recent report, the emerging market for protein microarrays will experience strong growth buoyed on by the emergence of the technology's ability to detect protein expression more quickly and easily than traditional approaches such as 2D...
UK drug delivery company Phoqus has said it plans to list on the Alternative Investment Market (AIM) via an institutional placing that should raise proceeds of £10-£12 million.
India's Matrix Laboratories has made two acquisitions that will enhance its presence in the European and Asian markets for pharmaceutical intermediates and active pharmaceutical ingredients (APIs).
Two novel technologies, designed to check water supplies for toxins, is set to provide a new on-site monitoring approach, enhancing current utility monitoring systems that require water samples to be sent to laboratories for analysis.